Suppr超能文献

造血干细胞移植后的血流感染与死亡率增加相关。

Blood stream infection after hematopoietic stem cell transplantation is associated with increased mortality.

作者信息

Poutsiaka D D, Price L L, Ucuzian A, Chan G W, Miller K B, Snydman D R

机构信息

Division of Geographic Medicine and Infectious Diseases, Department of Medicine, Tufts-New England Medical Center, Boston, MA 02111, USA.

出版信息

Bone Marrow Transplant. 2007 Jul;40(1):63-70. doi: 10.1038/sj.bmt.1705690. Epub 2007 Apr 30.

Abstract

Blood stream infection (BSI) is a serious complication of hematopoietic stem cell transplantation (HSCT). The aim of this retrospective cohort analysis was to describe BSI after HSCT, and to assess the predictors and outcomes of BSI after HSCT using multivariable modeling. Of the 243 subjects transplanted, 56% received allogeneic HSCT and 106 (43.6%) developed BSI. Of the 185 isolates, 68% were Gram-positive cocci, 21% were Gram-negative bacilli (GNR) and 11% were fungi. Type of allogeneic HSCT was an independent risk factor for BSI (hazard ratio (HR) 3.26, 95% confidence interval (CI) 1.50, 7.07, P = 0.01), as was the degree of HLA matching (HR 1.84, 95% CI 1.00, 3.37, P = 0.05). BSI was a significant independent predictor of mortality after HSCT (HR 1.79, 95% CI 1.18, 2.73, P = 0.007), after adjusting for acute graft-versus-host disease (GVHD) and allogeneic HSCT (both predicting death < or = 3 months after HSCT). In contrast to the effects of acute GVHD and allogeneic HSCT, the effect of BSI was evident throughout the post-HSCT period. GNR BSI and vancomycin-resistant enterococcal BSI also were significantly associated with death. We concluded that BSI is a common complication of HSCT associated with increased mortality throughout the post-HSCT period.

摘要

血流感染(BSI)是造血干细胞移植(HSCT)的一种严重并发症。这项回顾性队列分析的目的是描述HSCT后的BSI情况,并使用多变量模型评估HSCT后BSI的预测因素和结局。在243例接受移植的受试者中,56%接受了异基因HSCT,106例(43.6%)发生了BSI。在185株分离菌株中,68%为革兰氏阳性球菌,21%为革兰氏阴性杆菌(GNR),11%为真菌。异基因HSCT的类型是BSI的独立危险因素(风险比[HR] 3.26,95%置信区间[CI] 1.50,7.07,P = 0.01),HLA匹配程度也是如此(HR 1.84,95% CI 1.00,3.37,P = 0.05)。在调整了急性移植物抗宿主病(GVHD)和异基因HSCT(两者均预测HSCT后≤3个月死亡)后,BSI是HSCT后死亡率的显著独立预测因素(HR 1.79,95% CI 1.18,2.73,P = 0.007)。与急性GVHD和异基因HSCT的影响相反,BSI的影响在HSCT后的整个时期都很明显。GNR BSI和耐万古霉素肠球菌BSI也与死亡显著相关。我们得出结论,BSI是HSCT的常见并发症,与HSCT后整个时期死亡率增加相关。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验